ATE136468T1 - VACCINE FOR TREATING HSV - Google Patents

VACCINE FOR TREATING HSV

Info

Publication number
ATE136468T1
ATE136468T1 AT87907206T AT87907206T ATE136468T1 AT E136468 T1 ATE136468 T1 AT E136468T1 AT 87907206 T AT87907206 T AT 87907206T AT 87907206 T AT87907206 T AT 87907206T AT E136468 T1 ATE136468 T1 AT E136468T1
Authority
AT
Austria
Prior art keywords
hsv
vaccine
vaccines
disease
treatment
Prior art date
Application number
AT87907206T
Other languages
German (de)
Inventor
Rae Lyn Burke
Carol Pachl
Pablo D T Valenzuela
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE136468T1 publication Critical patent/ATE136468T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

Vaccines and therapeutic compositions useful for therapeutic treatment of disease caused by Herpes Simplex Virus (HSV). These vaccines and compositions employ recombinant HSV glycoproteins B and D. Treatment of an HSV infected individual with the vaccine or composition subsequent to infection with HSV alleviates recurrent disease due to HSV, even if the individual is treated during an acute phase of the disease when HSV induced lesions are present.
AT87907206T 1986-10-20 1987-10-20 VACCINE FOR TREATING HSV ATE136468T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92121386A 1986-10-20 1986-10-20
US7960587A 1987-07-29 1987-07-29

Publications (1)

Publication Number Publication Date
ATE136468T1 true ATE136468T1 (en) 1996-04-15

Family

ID=26762199

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87907206T ATE136468T1 (en) 1986-10-20 1987-10-20 VACCINE FOR TREATING HSV

Country Status (6)

Country Link
EP (1) EP0289550B1 (en)
AT (1) ATE136468T1 (en)
CA (1) CA1337395C (en)
DE (1) DE3751772T2 (en)
HK (1) HK148296A (en)
WO (1) WO1988002634A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151267A (en) * 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
US5585264A (en) * 1988-07-15 1996-12-17 University Of Saskatchewan Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides
DE69019609T2 (en) * 1989-07-07 1995-11-30 Takeda Chemical Industries Ltd Proteins and their production.
DE69131200T2 (en) * 1990-08-02 1999-12-09 Chiron Corp HERPES SIMPLEX VIRUS VP16 VACCINE
US5241053A (en) * 1990-09-05 1993-08-31 Takeda Chemical Industries, Ltd. Fused proteins comprising glycoprotein gD of HSV-1 and LTB
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
KR100198868B1 (en) * 1991-07-25 1999-06-15 케네쓰 제이. 울코트 Composition for the induction of cytotoxic t-lymphocyte responses
US5709860A (en) * 1991-07-25 1998-01-20 Idec Pharmaceuticals Corporation Induction of cytotoxic T-lymphocyte responses
US5679348A (en) * 1992-02-03 1997-10-21 Cedars-Sinai Medical Center Immunotherapy for recurrent HSV infections
GB9409962D0 (en) * 1994-05-18 1994-07-06 Smithkline Beecham Biolog Novel compounds
AU1273495A (en) * 1994-12-06 1996-06-26 Bruschettini S.R.L. Glycoproteins from herpes virus and vaccines containing them
GB2336367B (en) * 1998-04-15 2002-03-27 Johnson & Johnson Medical Ltd Polyurethane foams for use in wound dressings
CA2689696C (en) 1999-02-26 2013-08-06 Novartis Vaccines And Diagnostics, Inc. Microemulsions with adsorbed macromolecules and microparticles
EP1670507A4 (en) 2003-09-12 2007-10-17 Antigenics Inc Vaccine for treatment and prevention of herpes simplex virus infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051120A (en) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst Herpes simplex subunit vaccine
US4642333A (en) * 1983-09-16 1987-02-10 Stanley Person Immunologically reactive non-glycosylated amino acid chains of glycoprotein B of herpes virus types 1 and 2
EP0628633B1 (en) * 1984-04-06 2003-01-08 Chiron Corporation Recombinant herpes simplex gB-gD vaccine

Also Published As

Publication number Publication date
CA1337395C (en) 1995-10-24
EP0289550A4 (en) 1989-12-28
EP0289550A1 (en) 1988-11-09
HK148296A (en) 1996-08-09
WO1988002634A1 (en) 1988-04-21
DE3751772T2 (en) 1996-12-05
DE3751772D1 (en) 1996-05-15
EP0289550B1 (en) 1996-04-10

Similar Documents

Publication Publication Date Title
ATE136468T1 (en) VACCINE FOR TREATING HSV
PT1296711E (en) E7 FOR THE TREATMENT OF HUMAN PAPILOMA VIRUS
DE69535758D1 (en) LIPID ANALOGUE FOR THE TREATMENT OF VIRAL INFECTIONS
EA200600582A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL HEPATITIS C
PT83434B (en) PROCESS OF PREPARATION OF RECOMBINANT, PEPTID, PROTEIN AND VACCINE VIRUSES AGAINST THE ACQUIRED IMMUNODEFICIENCY SYNDROME
PT93393A (en) PROCESS FOR THE PREPARATION OF VACCINES AND DIAGNOSTIC AGENTS CONTAINING PROTEIN IMMUNOGENIC REGIONS OF HUMAN PAPILOMA VIRUS OF TYPE 16 OR ANTIBODIES INVOLVED AGAINST THESE REGIONS
ATE475423T1 (en) IMMUNO-STIMULATING POLYNUCLEOTIDE SEQUENCES FOR USE IN PREVENTING AND TREATING VIRAL DISEASES
ATE116637T1 (en) SULFONIC STILBEN DERIVATIVES FOR THE TREATMENT OF VIRUS DISEASES.
ATE101648T1 (en) EXPRESSION OF A TUMOR-SPECIFIC ANTIGEN OF A RECOMBINANT VIRUS VECTOR AND ITS APPLICATION FOR THE CARE OR CURATIVE TREATMENT OF THE RELEVANT TUMORS.
ATE165345T1 (en) SULFONIC ACID DERIVATIVES FOR THE TREATMENT OF VIRUS DISEASES
DE68906735D1 (en) PHARMACEUTICAL PREPARATION FOR TREATING VIRUS DISEASES WITH LIVER EXTRACT.
DE69230643T2 (en) METHOD FOR TREATING VIRAL INFECTIONS
DE68912155D1 (en) Combination antiviral.
NO923824D0 (en) USE OF TRINITROBENZENES OR CARCAMIC ACID IN TREATMENT OF CANCER OR VIRUS DISEASES
DE3767308D1 (en) USE OF SULFONAMIDE DERIVATIVES FOR THE PRODUCTION OF AN ANTIVIRUS.
DE69004451T2 (en) Prophylaxis and treatment of herpes virus infections.
ES2162862T3 (en) USE OF TIMOSINE TO TREAT HEPATITIS C IN PATIENTS WHO DO NOT RESPOND TO THE INTERFER TREATMENT.
ATE155795T1 (en) USE OF LEUKOREGULIN FOR THE TREATMENT OF ANIMAL INFECTED WITH AN ENVELOPE VIRUS
DK384387A (en) ERYTHROMYCINE DERIVATIVES FOR PREVENTION AND TREATMENT OF DISEASES Caused by Viruses
DK257887A (en) PROCEDURE FOR PREPARING HBCAG IN YEARS AND PLASMID TO USE IN EXERCISE OF THE PROCEDURE
ATE255417T1 (en) USE OF BRADYKININ ANTAGONISTS TO TREAT VIRUS DISEASES
EA199700353A1 (en) Compositions and methods for detecting and treating acquired immunodeficiency syndrome
ATE126704T1 (en) BCRF1 ANTAGONISTS FOR THE TREATMENT OF EPSTEIN BARR VIRUS INFECTIONS.
RU94038588A (en) Method of secondary immunodeficiency treatment
DE69006187T2 (en) Use of quinolyl- and isoquinolyloxazol-2-ones for the manufacture of a medicament for the prevention of the contagiousness of viruses enveloped with glycoproteins.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time